Shifting Sands: Unveiling the Changes in Respiratory Comorbidities and Fungal Pathogens in Saudi Arabia

Overview

Journal Saudi Med J

Specialty General Medicine

Date 2025 Feb 11

PMID 39933763

Authors

Aiah M Khateb

Fadwa S Alofi

Mohammad A Alturkostani

Abdullah Z Almutairi

Affiliations

Soon will be listed here.

Abstract

Objectives: To investigate epidemiological changes in respiratory fungal infections (RFI), including fungal isolation and colonization, at one of the main centers in Medina. The incidence of RFI is rising due to an increase in the number of immunocompromised individuals, a higher prevalence of respiratory viral infections, and an aging population.

Methods: A retrospective cross-sectional study was conducted by extracting data of patients with fungal-positive respiratory cultures from King Fahad Hospital (KFH), Al Madinah Al Munawwarah from 2013 to 2023.

Results: A total of 352 episodes of fungal-positive cultures were identified in 79 patients, reflecting a 12-fold increase in RFI prevalence. The most frequent fungus was 43% (n=150), followed by at 34% (n=119), at 7% (n=25), at 5% (n=18), at 3.4% (n=12), and at 3.4% (n=12). Bronchoalveolar lavage was performed 52 times, with 19 cultures growing and 8 cultures positive for . None of the 58 lung biopsy samples grew mold. Only one patient had 2 isolates resistant to voriconazole and fluconazole. The most prevalent comorbidities were respiratory diseases (30%) and lower limb injuries and diabetes (16%).

Conclusion: was the leading cause of RFI. Continuous monitoring, improved diagnostics, and targeted interventions are crucial to address existing challenges and emerging threats. The growing recognition of fungal infections necessitates increased research and education for healthcare professionals.

References

Shajiei A, Liu L, Seinen J, Dieperink W, Hammerschmidt S, van Dijl J . Specific associations between fungi and bacteria in broncho-alveolar aspirates from mechanically ventilated intensive care unit patients. Virulence. 2022; 13(1):2022-2031. PMC: 9673952. DOI: 10.1080/21505594.2022.2146568. View

Aljishi A, Alalbdulhadi D, Alabbadi G, Ali M, Ivey M, AlMusa Z . Diagnostic Utility of Bronchoalveolar Lavage in Immunocompromised Patients with Lung Infiltrates. Saudi J Med Med Sci. 2023; 11(2):169-174. PMC: 10211421. DOI: 10.4103/sjmms.sjmms_363_22. View

Budden K, Shukla S, Rehman S, Bowerman K, Keely S, Hugenholtz P . Functional effects of the microbiota in chronic respiratory disease. Lancet Respir Med. 2019; 7(10):907-920. DOI: 10.1016/S2213-2600(18)30510-1. View

Pendleton K, Huffnagle G, Dickson R . The significance of Candida in the human respiratory tract: our evolving understanding. Pathog Dis. 2017; 75(3). PMC: 6433300. DOI: 10.1093/femspd/ftx029. View

Liu J, Yu Y, Xu C, Chen D . Colonization in the Respiratory Tract: What Is the Significance?. Front Med (Lausanne). 2021; 7:598037. PMC: 7889970. DOI: 10.3389/fmed.2020.598037. View

Pendleton K, Dickson R, Newton D, Hoffman T, Yanik G, Huffnagle G . Respiratory Tract Colonization by species Portends Worse Outcomes in Immunocompromised Patients. Clin Pulm Med. 2019; 25(6):197-201. PMC: 6430131. DOI: 10.1097/CPM.0000000000000279. View

Khateb A, Alkhaibari S . Cross-sectional investigation of mycological diagnosis challenges in Saudi Arabia. Front Cell Infect Microbiol. 2023; 13:1203892. PMC: 10332264. DOI: 10.3389/fcimb.2023.1203892. View

Nguyen L, Viscogliosi E, Delhaes L . The lung mycobiome: an emerging field of the human respiratory microbiome. Front Microbiol. 2015; 6:89. PMC: 4327734. DOI: 10.3389/fmicb.2015.00089. View

Su W, Feng J, Chiu Y, Huang S, Lee Y . Role of 2-month sputum smears in predicting culture conversion in pulmonary tuberculosis. Eur Respir J. 2010; 37(2):376-83. DOI: 10.1183/09031936.00007410. View

10.

Donnelly J, Chen S, Kauffman C, Steinbach W, Baddley J, Verweij P . Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis. 2019; 71(6):1367-1376. PMC: 7486838. DOI: 10.1093/cid/ciz1008. View

11.

Maiz L, Vendrell M, Olveira C, Giron R, Nieto R, Martinez-Garcia M . Prevalence and factors associated with isolation of Aspergillus and Candida from sputum in patients with non-cystic fibrosis bronchiectasis. Respiration. 2015; 89(5):396-403. DOI: 10.1159/000381289. View

12.

Saubolle M, McKellar P . Laboratory diagnosis of community-acquired lower respiratory tract infection. Infect Dis Clin North Am. 2002; 15(4):1025-45. PMC: 7126342. DOI: 10.1016/s0891-5520(05)70185-9. View

13.

Borghi E, Iatta R, Sciota R, Biassoni C, Cuna T, Montagna M . Comparative evaluation of the Vitek 2 yeast susceptibility test and CLSI broth microdilution reference method for testing antifungal susceptibility of invasive fungal isolates in Italy: the GISIA3 study. J Clin Microbiol. 2010; 48(9):3153-7. PMC: 2937670. DOI: 10.1128/JCM.00952-10. View

14.

Bongomin F, Gago S, Oladele R, Denning D . Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision. J Fungi (Basel). 2018; 3(4). PMC: 5753159. DOI: 10.3390/jof3040057. View

15.

Ostermann H, Bryan J . New therapeutic approaches to managing invasive fungal infections: report from the 17th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) and the 25th International Congress of Chemotherapy (ICC), 31 March-3 April 2007,.... Int J Antimicrob Agents. 2007; 30(4):377-80. DOI: 10.1016/j.ijantimicag.2007.06.004. View